Hobart Group Holdings Marks 10th Anniversary With Multiple Milestones

GLADSTONE, N.J., May 6, 2013 /PRNewswire/ -- In 2003, Lisa B. Bair opened The Hobart Group in her home with one client and $200,000 in revenue. Over 10 years, Hobart Group Holdings has grown into a $30+ million company with 115 employees and 3 offices and manages business for 12 of the top 20 global pharmaceutical companies. The icing on the anniversary cake was securing the Agency of the Year nomination by industry experts.

"Our unbelievable growth over the past 10 years stems from a culture that thrives on the passion to discover new approaches that improve patient care through innovative customer initiatives," says Bair. "Hobart has always been the agency to raise the bar, set the trends, and create new tools in the managed markets space. 2013 will be no different—we are committed to further elevating the space with new product initiatives and distinctive, game-changing alliances," says the Founder and CEO of Hobart Group Holdings.

Hobart Group Holdings provides comprehensive access and reimbursement support to an impressive client base that includes many of the largest global pharmaceutical companies—Lilly, Sanofi, Pfizer, GlaxoSmithKline, Merck, Bayer HealthCare, and Astellas, to name a few.

The company's growth has not gone unrecognized. Over the past few years, Hobart has received many accolades, including

• 2010: Ernst & Young named Bair one of the top 10 women entrepreneurs in the United States
• 2011: Hobart was recognized as one of the 50 Fastest Growing Women-Owned/Led Companies™ in North America awarded by the Women Presidents' Organization and American Express
• 2011 and 2012: Hobart was listed in Inc. magazine's top 500/5000 Fastest Growing Companies 
• 2012 and 2013: Hobart was honored as one of the Best Places to Work in New Jersey
• 2013: Hobart was nominated for Agency of the Year by Med Ad News

"Our exceptional growth and success is attributed to the fact that Hobart Group Holdings is the largest dedicated payer agency in the United States. The pharmaceutical industry has recognized the advantage Hobart offers as a payer-focused agency and continually seeks out Hobart to assist in developing customized access and reimbursement approaches," says Dan Renick, RPh, President of Hobart Group Holdings.

Future Plans

Hobart Innovations, a division of Hobart Group Holdings under the leadership of Larry Blandford, is developing digital enterprise capabilities designed to improve the dialogue and align objectives between payers and pharmaceutical companies. The new products will provide tremendous opportunities for pharma clients to elevate the dialogue with payer customers. 

About Hobart Group Holdings

Hobart Group Holdings is a consortium of 3 full-service, thought-leader agencies, including The Hobart Group in New Jersey, Hobart Forte in New York City, and Hobart Core in Chicago.

Hobart's core competencies include payer value proposition development, launch planning, payer market research, quality initiatives, HEOR, sales training, and contracting and pricing expertise.

What sets Hobart apart is the strategic services department, which is composed of former payer decision makers with extensive knowledge across the spectrum of organized customer channels. The strategic team has more than 100 years of experience working with, and working as, pharmacy directors, medical directors, contracting managers, case managers, and quality directors for MCOs, PBMs, government, payers, IDNs, hospitals, and LTC facilities. This experience allows Hobart to consistently deliver impactful solutions that directly align with clients' marketing objectives.

SOURCE Hobart Group Holdings